Gliapharm is a startup based in Switzerland. Brouky records 1 investor associated with the company.
A Swiss biotechnology company that develops treatments for neurological and psychiatric disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.